(Q42623441)

3 November 2017

title

Cholestatic jaundice, an unusual side effect of etretinate (English)

1 reference

3 November 2017

D Gavish

1

1 reference

3 November 2017

M Katz

2

1 reference

3 November 2017

N Gottehrer

3

1 reference

3 November 2017

A Israeli

4

1 reference

3 November 2017

G Lijovetzky

5

1 reference

3 November 2017

K Holubar

6

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 October 1985

1 reference

Journal of the American Academy of Dermatology

3 November 2017

published in

1 reference

3 November 2017

volume

13

1 reference

3 November 2017

issue

4

1 reference

3 November 2017

page(s)

669-670

1 reference

A study of potential hepatotoxicity of etretinate used in the treatment of psoriasis

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2980450-3

7 January 2021

Side effects due to RO 10-9359 (Tigason). A retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2980450-3

7 January 2021

Laboratory investigations in patients with generalized psoriasis under oral retinoid treatment. A multicenter study of computerized data

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2980450-3

7 January 2021

Histologic changes in the liver during etretinate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2980450-3

7 January 2021

Etretinate (Tigason) hepatitis in 2 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2980450-3

7 January 2021

A case of centrolobular toxic necrosis of the liver due to aromatic retinoid--Tigason (Ro 10-9359)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2885%2980450-3

7 January 2021

10.1016/S0190-9622(85)80450-3

Identifiers

DOI

1 reference

3 November 2017

1 reference